Breast cancer is the most common malignant tumor among women accounting for 25.1% of all cancers and is among the main causes of death in women. 1 Advances in medical research have dramatically improved the treatment of this disease over the last 50 year. 2 In addition to chemotherapy and radiation therapy, partial and complete mastectomy of diseased and contralateral breasts has become more frequent. 3 However, these surgical modalities often leave patients with anatomical deformities and altered body image, along with the psychological impact. 4
carcinoma. 6 It minimizes deformity and improves cosmoses through the preservation of the natural skin envelope of the breast. 7 The latissimus dorsi (LD) myocutaneous flap remains an excellent choice for breast reconstruction with a low risk of complications and doesn't interfere with radiotherapy and chemotherapy. 8 This study was performed to compare SSM with immediate LD flap and delayed breast reconstruction with LD flap after modified radical mastectomy.
METHODS
This prospective clinical study was conducted at the department of general surgery Menofiua university hospitals from April 2017 to March 2019, it included 20 patients with early breast cancer divided into two groups: group one included 10 patients did SSM, group two included 10 patients did delay LD flap. All patients signed for informed consents for photography before and after surgical procedures.
Inclusion criteria
Patients with early-stage breast cancer who are preferring mastectomy and immediate reconstruction; patient with T1, or T2 lesions, not candidates for breast-conserving therapy because of small breast tumor ratio, centrally located tumors, evidence of multi centricity and radiotherapy intolerance; isolated breast recurrence after breast conservation therapy; patients with DCIS necessitating mastectomy and patients who are scheduled for prophylactic mastectomy.
Exclusion criteria
Exclusion criteria were locally advanced breast cancer (T3, T4 lesions); metastatic disease and inflammatory breast cancer; patients who have breast skin disease or systemic skin disease (scleroderma-telangiectasia); patient older than 60 yrs; or with medical disease contraindicating prolonged anesthesia; patients who don't prefer breast reconstruction. 
In group one patient who did SSM
Under general anesthesia in supine position preoperative marking of the inframammary crease ( Figure 1A ). Elliptical peri-areolar skin incision with medial and lateral extensions, including nipple-areola complex, biopsy site, and skin overlying superficial tumor if possible ( Figure 1D ). The skin flap is elevated superficial to enveloping fascia of the breast with 2 to 3 mm thickness in thin patient and 5 to 10 mm in a fat patient. 9 All glandular tissue including pectoralis fascia is removed as in the standard procedure of modified radical mastectomy as we free the gland from the subcutaneous tissue medial to the parasternal line and then move to the second intercostal space with respect of inframammary crease caudally ( Figure 1E ). Laterally to the anterior axillary fold. In a superficial tumor, we did meticulous dissection and frozen section to ensure a free margin of skin overlying. 9 A separate axillary incision is made transversely behind the border of pectoralis major muscle to expose the axilla, and axillary dissection is performed in continuity with breast tail removing all levels of axillary nodes (I, II and III). 10
In-group 2 who did delayed reconstruction
Elliptical incision, including the previous scar, is done with upper and lower flap. 4-6 weeks pre-operative tissue expander may be helpful to provide adequate skin length. The incision extends to the axilla. 10
Autologous LD flap in both groups
The patient is in the lateral position. The line of the cutaneous paddle is made in the posterolateral thoracic region ( Figure 1B ), in a crescent shape, opening upward. At the back, the rear tip of the cutaneous crescent comes almost to the anterior axillary line and passes a few centimeters from the anterior edge of the LD muscle ( Figure 1F ). The cutaneous paddle is detached in all sides while talking of the fat on the surface of the muscle; it is necessary to free the main pedicle completely and to dissect it almost to the circumflex scapular artery. 11 A subtotal section of LD tendon is made in such a way as to leave a small muscular bridge protecting the vascular pedicle from stretching. The completely raised flap is then passed to the anterior thoracic region. The flap is put in the subcutaneous layer in place of the breast over pectoralis major Ms ( Figure 1J ) using absorbable 2/0 suture. Then closure of skin is performed over 2 drains. 12 Then closure of donor site wound ( Figure 1K ).
Statistical analysis
All data were collected, tabulated and statistically analyzed the descriptive measures of central tendency (mean and median) and measures for dispersion (range and standard deviation), besides frequency and percentages were calculated by SPSS 20 (statistical package for the social science, SPSS Inc., Chicago, IL, USA).
RESULTS
Analysis of the data of 20 patients divided into two groups: group one include 10 patients who did SSM with immediate LD flap and group two include 10 patients who did delayed LD flap after a previous modified radical mastectomy. Patients in the study were selected to have early-stage breast cancer (stage I and II). (10 cases), two patients (20%) had undergone SSM for T1 tumors, and eight patients (80%) for T2 tumors (Figure 2 ). All patients were scheduled for complete axillary dissection, including all axillary levels (I, II, and III). Grade II tumors were reported in sixteen cases (80%) and grades I reported in one case (5%). In addition, grade III reported in three cases (15%). Regarding the nodal status, twelve patients (60%) had positive axillary nodes, and eight patients (40%) had negative axillary nodes ( Table  2) . P=0.008 is highly significant.
The operative time was calculated from the induction of anesthesia until patient recovery. In cases of SSM LD flap reconstruction, in group one the average time was 4.95 hours with a range of 4-6.5 hours, and a median of 4.75 hours with SD ±0.89 while in cases of group two who did delay LD flap, the average time was 2.4 hours with a range of 1.5-3.5 hours and a median of 2.5 hours. With SD ±0.65, the difference was statistically significant (Figure 3 ).
Complications following SSM classified into early (in the 1st month) and late (after 1 month) and were compared in patients who underwent LD flap. In the first group, there was 1 case (10%) of partial flap necrosis and no partial flap necrosis in-group two. Wound debridement was done one week postoperatively, and repeated dressings were done until the wound was completely clean. Then the wound was restored on cases of the total flap. Hematoma under the flap was observed in one case (10%) in group one and was evacuated. Seroma was the commonest complication following LD flap reconstruction and occurred in 2 cases (20%) in both groups and was treated by repeated aspirations. Minor wound infection was observed in one case both groups (20%) all not necessitated secondary sutures, all treated by local measures. Fat necrosis was observed in 2 cases (20%).
Late complications like hypertrophic scarring found one case (10%) in the first group and two cases (20%) in the second group.
The cosmetic results in this series were more than acceptable. 6 patients (30%) satisfied, and eleven patients are pleased (55%) while only three patients (15%) unsatisfied.
DISCUSSION
The surgical management of breast cancer has been changed radically from the Halsted mastectomy to the modified mastectomy to lumpectomies and irradiation and now to SSM. SSM is the treatment of choice for many women with early-stage breast cancer and improves breast reconstruction results in several ways. 13 In present work, we agree with that as SSM with immediate LD flap does not increase the risk of recurrence, is cosmetically acceptable, and there is no need for another operation for reconstruction. Immediate breast reconstruction does not interfere with the resumption of chemotherapy or the ability to detect locoregional recurrence. The cosmetic result was dependent on the initial outcome of the reconstruction. If fat necrosis was present, however, irradiation tended to accentuate fibrosis and volume loss. 15 In present work, adjuvant, therapy was delivered after a period ranged from 6 to 8 weeks. No delay in adjuvant therapy occurred after LD flap; adjuvant therapy was delayed due to partial flap necrosis and fat necrosis.6 patients receive chemotherapy (CTH) in SSM and 4 in LD flap. 3 cases receive radiotherapy in SSM and nine cases in LD flap, (5 patients in SSM and 6 in LD flap receive Hormonal therapy. We reported only one case ingroup one who did SSM had partial flap necrosis.
It is well established that radiotherapy contributes to inferior outcomes and complication rates in prosthetic breast reconstruction; the complication in autologous reconstruction is, volume loss and inferior aesthetic outcome for immediate reconstruction after radiotherapy compared with delayed reconstruction or immediate reconstruction without radiotherapy but these differences are insignificant. The complication rate in the group who had primary reconstruction without radiotherapy was not significantly different from the group who had primary reconstruction with a radiotherapy complication rate of PMRT following autologous breast reconstruction ranges from 5% to 16%. Volume loss, endarteritis with flap failure, fat or flap necrosis skin ulceration, and acute toxicity is the common complication. In the present work, most of the patients have received postoperative radiotherapy. Three cases who did immediate reconstruction a good to excellent cosmoses with only one case of partial flap necrosis and one case had fat necrosis, in cases who had done delayed LD flap nine had previous radiotherapy one only had fat necrosis and treated by lipo-injection.
CONCLUSION
Immediate breast reconstruction does not impair the oncologic safety of breast cancer management, with no increase in local recurrence rates, and no delays in the initiation of adjuvant chemotherapy or radiation therapy.
